Skip to content
VuFind
  • Login
    • English
    • اللغة العربية
Advanced
  • Formulas and criteria for sign...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Formulas and criteria for signal detection algorithms in pharmacovigilance.

Formulas and criteria for signal detection algorithms in pharmacovigilance.

<p>Formulas and criteria for signal detection algorithms in pharmacovigilance.</p>

Saved in:
Bibliographic Details
Main Author: Yinrui Fang (22169878) (author)
Other Authors: Zilun Wu (18696883) (author), Qian Wu (209382) (author), Gangyi Chen (381813) (author)
Published: 2025
Subjects:
Medicine
Cell Biology
Genetics
Neuroscience
Pharmacology
Biotechnology
Evolutionary Biology
Immunology
Developmental Biology
Cancer
Mental Health
Infectious Diseases
Virology
world safety data
sodium zirconium cyclosilicate
g ., ileus
four disproportionality algorithms
associated adverse events
564 ae reports
2004 &# 8211
term risks remain
novel hyperkalemia therapy
identified safety signals
cardiac adverse events
previously unreported aes
aes peaked early
signals met
previously recognized
preferred term
initial therapy
early phase
xlink ">
ventricular fibrillation
using post
study highlights
study aimed
research design
prospective studies
inherent constraints
general disorders
findings suggest
cardiac failure
algorithm thresholds
2023 ).
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Similar Items

  • The signal values of adverse reactions associated with patiromer based on preferred terms.
    by: Yinrui Fang (22169878)
    Published: (2025)
  • The signal values of adverse reactions associated with sodium zirconium cyclosilicate based on preferred terms.
    by: Yinrui Fang (22169878)
    Published: (2025)
  • Baseline characteristics of the study.
    by: Yinrui Fang (22169878)
    Published: (2025)
  • Comparison of disproportionality signals for shared adverse events between SZC and patiromer.
    by: Yinrui Fang (22169878)
    Published: (2025)
  • Subgroup analyses stratified by gender and age.
    by: Yinrui Fang (22169878)
    Published: (2025)

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items
Cannot write session to /tmp/vufind_sessions/sess_i3948pp64cnp0ac01uhi052mnu